Rhonda Patrick on health: what the evidence says · JRE #1054
“they can kill cancer cells almost as good as the chemo control that they're giving these animals”
What the evidence says
Patrick's statement traces to a widely cited 2015 mouse study (Sivan et al., Science) in which oral administration of a single probiotic strain, Bifidobacterium, improved control of implanted melanoma tumors in mice to a degree similar to treatment with an anti-PD-L1 checkpoint-blockade antibody, and combining both nearly eliminated tumor growth. That comparator, however, was cancer immunotherapy (a PD-L1 antibody), not conventional cytotoxic chemotherapy as described in the quote, so the "chemo control" framing mischaracterizes what was actually tested. The effect was driven by enhanced dendritic cell function and CD8+ T cell activity in a single mouse tumor model using a single bacterial strain, and has not been shown to reproduce comparable tumor-killing efficacy to chemotherapy or immunotherapy in human cancer patients. Subsequent research on gut microbiota and probiotics in cancer immunotherapy has expanded on this mechanism but remains largely preclinical or correlational in humans, with no probiotic approved or established as an alternative or equivalent to chemotherapy for treating cancer.
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy - PubMed · government
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy - PMC · government
- Microbiota: a key orchestrator of cancer therapy - Nature Reviews Cancer · journal